Quality
Confidence begins with what can be verified.
A reported purity percentage is only one part of evaluating a research compound. Suria's quality approach is centered around product identity, analytical documentation, supplier qualification, batch traceability and appropriate third-party testing.
Analytical Verification
What gets checked, and how it's shared.
Where third-party analytical testing has been completed, Suria makes the corresponding documentation available so researchers can review the reported results directly.
Testing may include identity and purity analysis and, where applicable, additional analytical testing appropriate to the compound or batch.
Batch Documentation
Documentation tied to the batch it represents.
Documentation should correspond to the product and batch it represents. As Suria's catalog and testing program expand, available batch-specific documentation will be accessible through the appropriate product or documentation area.
Responsible Presentation
Data, not claims.
Suria does not use analytical testing to make claims about clinical safety, effectiveness or suitability for human use.
Laboratory analytical results describe characteristics of the submitted research sample. They do not convert a research compound into an approved pharmaceutical product.
Continuous Standards
Built to evolve with the catalog.
Our quality program is designed to evolve as the Suria catalog grows. Additional analytical testing may be incorporated based on compound characteristics, supplier qualification, batch requirements and available testing methodologies.